This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Veeva Expands Quality Cloud With New EHS Risk Management Solution
by Zacks Equity Research
VEEV's Veeva EHS expands Quality Cloud with automated risk, compliance and safety workflows, aiming to replace legacy systems with a unified platform.
VEEVPositive Net Change ISRGNegative Net Change GMEDPositive Net Change BTSGNegative Net Change
medical medical-devices
Should You Buy Vornado (VNO) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VNOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?
by Moumi Mondal
DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to watch now.
ABTNegative Net Change DXCMPositive Net Change
medical medical-devices
Is it the Right Time to Add Labcorp Stock to Your Portfolio?
by Zacks Equity Research
LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds could weigh on results.
LHNegative Net Change ALGNPositive Net Change IARTPositive Net Change GMEDPositive Net Change
medical medical-devices
AMN Expands Workforce Intelligence Through Brightfield Alliance
by Zacks Equity Research
AMN Healthcare's alliance with Brightfield boosts workforce intelligence, pairing TDX with analytics to support smarter healthcare labor planning.
AMNPositive Net Change ISRGNegative Net Change WSTNegative Net Change GMEDPositive Net Change
medical medical-devices
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
by Zacks Equity Research
INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.
INGNPositive Net Change WSTNegative Net Change GMEDPositive Net Change BTSGNegative Net Change
medical medical-devices
NTRA's Signatera Secures PMDA Approval for MRD Testing in CRC in Japan
by Zacks Equity Research
Natera's Signatera gains Japan PMDA approval for CRC, marking the country's first approved MRD test and advancing its global expansion.
NTRANegative Net Change ISRGNegative Net Change GMEDPositive Net Change BTSGNegative Net Change
medical medical-devices
4 Value Stocks to Buy as Lower Energy Costs Strengthen Market Outlook
by Sumit Singh
Nexa Resources, Avnet, StoneCo and USANA Health stand out as lower oil prices ease inflation worries and boost the case for value stocks.
AVTPositive Net Change USNANegative Net Change NEXAPositive Net Change STNEPositive Net Change
basic-materials computers medical medical-devices tech-stocks
Top Research Reports for Shell, Novo Nordisk & SAP
by Mark Vickery
Shell, Novo Nordisk and SAP headline Zacks' top research reports, highlighting growth drivers, guidance outlooks and key risks shaping performance.
INTCNegative Net Change ACNNegative Net Change NVOPositive Net Change BHPPositive Net Change SAPNegative Net Change RAVENo Net Change VASOPositive Net Change SHELPositive Net Change
computers medical-devices oil-energy pharmaceuticals restaurants
MiniMed Launches Abbott's Instinct Sensors Across European Markets
by Zacks Equity Research
MMED expands its European diabetes tech reach with Abbott sensor integration, boosting user flexibility and its connected care ecosystem.
ABTNegative Net Change WSTNegative Net Change GMEDPositive Net Change MMEDPositive Net Change
medical medical-devices